logo

Last Update

This profile was last updated on 7/23/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Ernst Schaefer?

Ernst J. Schaefer

Chief Medical Officer

Boston Heart Diagnostics Corporation

HQ Phone:  (508) 877-8711

Direct Phone: (508) ***-**** ext. ***direct phone

Email: e***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Boston Heart Diagnostics Corporation

175 Crossing Boulevard Suite 100

Framingham, Massachusetts,01702

United States

Company Description

Boston Heart is focused on transforming the treatment of cardiovascular disease by providing healthcare providers and their patients with novel diagnostics and reports as well as a personalized, scientifically designed nutrition and lifestyle program. These ha...more

Find other employees at this company (384)

Background Information

Employment History

Professor

Friedman School of Nutrition Science and Policy at Tufts University


Chairman of the Metabolism Study Section

National Institutes of Health


Chairman of the Metabolism Study Section

American Heart Association Inc


Professor of Medicine

Tufts-New England Medical Center


Affiliations

National Lipid Association

Board Member


Koyamindspace

Scientific Advisory Board Member


Koya Mind Space 2013

Scientific Advisory Board Member


PBM Pharmaceuticals Inc

Scientific Board Members Member


Who’s Who

Member


Vatera Holdings LLC

Advisory Board Member


Venue West Conference Services Ltd

Advisory Board Member


DHA & B Vitamins Center Blog

Scientific Board Members Member


Education

Phillips Academy


B.A. cum laude

Harvard University


JD Lane Award

American Heart Association


M.D.

Tufts University


MD

Dartmouth Medical School


MD

Harvard College


MD

Mount Sinai School of Medicine


honorable PhD

biochemistry and pharmacology

University of Buenos Aires


Web References(187 Total References)


Ernst Schaefer, MD | MANP

montanand.org [cached]

Ernst Schaefer, MD
Ernst J. Schaefer, MD, Founder and Chief Medical Officer Dr. Schaefer is internationally recognized as a leader in the field of lipoprotein metabolism, and the diagnosis and management of lipoprotein disorders for the prevention of Coronary Heart Disease. He has made countless contributions to the National Cholesterol Education Program (NCEP) of the National Institutes of Health (NIH) and is a member of the National Lipid Association's (NLA) Board of Directors. Dr. Schaefer founded Boston Heart Diagnostics Corporation with Dr. Bela Asztalos and Peter Parker in 2007, after developing the company's proprietary HDL measurement technology and the Boston Heart Cholesterol Balance® test. Dr. Schaefer is internationally recognized as a leader in the field of lipoprotein metabolism, and the diagnosis and management of lipoprotein disorders for the prevention of CHD. Dr. Schaefer is a distinguished professor at the Tufts University School of Medicine and the Friedman School of Nutrition Science and Policy at Tufts University, senior scientist at the Human Nutrition Research Center on Aging, as well as a senior scientist in the Cardiovascular Nutrition Laboratory in Boston, MA. He received the JD Lane Award of the U.S. Public Health Service and the National Institutes of Health (NIH) (1981) and the Irvine H. Page Arteriosclerosis Research Award from the American Heart Association (1981) for defining human HDL metabolism, the metabolic defect in Tangier disease and describing two new genetic disorders apoA-I/C-III/A-IV and apoE deficiency characterized by severe lipoprotein abnormalities and premature coronary heart disease with Drs. Dr. Schaefer is an author or co-author of over 500 publications and two books on HDL metabolism and heart disease prevention. He served on the first and second adult treatment panels of the National Cholesterol Education Program of the NIH, on the Nutrition Study Section and as chairman of the Metabolism Study Section of the NIH, and the Nutrition Committee of the American Heart Association. Between 1997 and 2007 Dr. Schaefer served as the U.S. editor of the journal Atherosclerosis, and in 2009 served as the chairman of the 15th International Symposium on Atherosclerosis, held in Boston. Dr. Schaefer received his education at Harvard College, Dartmouth Medical School, and the Mount Sinai School of Medicine (MD). He did his medical residency at Mt. Sinai Hospital, New York, and an endocrinology fellowship at the National Institutes of Health, where he also served as a senior investigator and head of the clinical service of the Molecular Disease Branch of the National Heart, Lung, and Blood Institute of NIH.


Executive Team | Boston Heart Diagnostics

www.bostonheartdiagnostics.com [cached]

Ernst Schaefer, MD, Founder and Chief Medical Officer
Ernst J. Schaefer, MD, Founder and Chief Medical Officer Dr. Schaefer is internationally recognized as a leader in the field of lipoprotein metabolism, and the diagnosis and management of lipoprotein disorders for the prevention of Coronary Heart Disease. He has made countless contributions to the National Cholesterol Education Program (NCEP) of the National Institutes of Health (NIH) and is a member of the National Lipid Association's (NLA) Board of Directors. Dr. Schaefer founded Boston Heart Diagnostics Corporation with Dr. Bela Asztalos and Peter Parker in 2007, after developing the company's proprietary HDL measurement technology and the Boston Heart Cholesterol Balance® test. Dr. Schaefer is internationally recognized as a leader in the field of lipoprotein metabolism, and the diagnosis and management of lipoprotein disorders for the prevention of CHD. Dr. Schaefer is a distinguished professor at the Tufts University School of Medicine and the Friedman School of Nutrition Science and Policy at Tufts University, senior scientist at the Human Nutrition Research Center on Aging, as well as a senior scientist in the Cardiovascular Nutrition Laboratory in Boston, MA. He received the JD Lane Award of the U.S. Public Health Service and the National Institutes of Health (NIH) (1981) and the Irvine H. Page Arteriosclerosis Research Award from the American Heart Association (1981) for defining human HDL metabolism, the metabolic defect in Tangier disease and describing two new genetic disorders apoA-I/C-III/A-IV and apoE deficiency characterized by severe lipoprotein abnormalities and premature coronary heart disease with Drs. Dr. Schaefer is an author or co-author of over 500 publications and two books on HDL metabolism and heart disease prevention. He served on the first and second adult treatment panels of the National Cholesterol Education Program of the NIH, on the Nutrition Study Section and as chairman of the Metabolism Study Section of the NIH, and the Nutrition Committee of the American Heart Association. Between 1997 and 2007 Dr. Schaefer served as the U.S. editor of the journal Atherosclerosis, and in 2009 served as the chairman of the 15th International Symposium on Atherosclerosis, held in Boston. Dr. Schaefer received his education at Harvard College, Dartmouth Medical School, and the Mount Sinai School of Medicine (MD). He did his medical residency at Mt. Sinai Hospital, New York, and an endocrinology fellowship at the National Institutes of Health, where he also served as a senior investigator and head of the clinical service of the Molecular Disease Branch of the National Heart, Lung, and Blood Institute of NIH. In 1999, Dr. Asztalos joined Dr. Schaefer's laboratory at Tufts University in Boston.


Speakers CCL

www.cardiocarelive.com [cached]

Ernst J. Schaefer, MD
Senior Scientist and Director at the Lipid Metabolism Laboratory Tufts University School of Medicine "Residual CV Risk: Where Have We Been And Where Are We Going?" Dr. Schaefer received his B.A. cum laude (biology) from Harvard University, his B.M.S. from Dartmouth Medical School, and his M.D. from Mount Sinai School of Medicine. He did a medical residency at Mt. Sinai Hospital, New York, and an endocrinology fellowship at the National Institutes of Health, where he also was a senior investigator and head of the clinical service of the Molecular Disease Branch of the National Heart, Lung, and Blood Institute. From NIH he received the JD Lane Award. Since 1982 he has been at Tufts University where he is currently a Distinguished University Professor at Tufts University School of Medicine and the Friedman School of Nutrition Science and Policy at Tufts University, a Senior Scientist and Director of the Lipid Metabolism Laboratory at the Human Nutrition Research Center on Aging at Tufts University, and the director of the Lipid and Heart Disease Prevention Clinic. He also serves as the Chief Medical Officer of Boston Heart Laboratory, Framingham, MA.


Scientific Advisory Board

www.bostonheartlab.com [cached]

Ernst J. Schaefer, MD
Chief Medical Officer Dr. Schaefer is Co-Founder and Chief Medical Officer of Boston Heart Lab. He and Dr. Asztalos (see below) have developed our company's proprietary technology to measure HDL particles and developed the revolutionary new method to use HDL particle concentrations as a much more effective predictor for cardiovascular disease (CVD). Dr. Schaefer is a distinguished professor at the Tufts University School of Medicine and the Friedman School of Nutrition Science and Policy at Tufts University. He received the J.D. Lane Award of the U.S. Public Health Service (1981) and the Irvine H. Page Arteriosclerosis Research Award from the American Heart Association (1981) for defining the metabolic defect in Tangier disease and describing two new genetic disorders apoA-I/C-III/A-IV and apoE deficiency characterized by severe lipoprotein abnormalities and premature heart disease. Further did Dr. Schaefer received the Saul Horowitz Research Award from Mt. Sinai School of Medicine (1989), Oliver Smith Awards of Tufts-New England Medical Center for Patient Care (1999, 2001, 2003), the E.V. McCollum Research Award of the American Society for Clinical Nutrition (2000), and a Distinguished Faculty Award from Tufts University (2001). Since 1997 he has been a member of Who's Who in America, and in 2004 was named among America's Top Physicians by the Consumers Research Council of America. Dr. Schaefer is an author or co-author of over 400 publications and served on the first and second adult treatment panels of the National Cholesterol Education Program of the National Institutes of Health, on the Nutrition Study Section and as chairman of the Metabolism Study Section of the NIH, and the Nutrition Committee of the American Heart Association. Since 1997 Dr. Schaefer has been the U.S. editor of the journal Atherosclerosis, the official journal of the European Atherosclerosis Society, and also serves on the Clinical Research Review Committee and Study Section of the NIH.


Executive Team | Boston Heart Diagnostics

www.bostonheartdiagnostics.com [cached]

Ernst Schaefer, MD, Founder and Chief Medical Officer
Ernst J. Schaefer, MD, Founder and Chief Medical Officer Dr. Schaefer is internationally recognized as a leader in the field of lipoprotein metabolism, and the diagnosis and management of lipoprotein disorders for the prevention of Coronary Heart Disease. He has made countless contributions to the National Cholesterol Education Program (NCEP) of the National Institutes of Health (NIH) and is a member of the National Lipid Association's (NLA) Board of Directors. Dr. Schaefer founded Boston Heart Diagnostics Corporation with Dr. Bela Asztalos and Peter Parker in 2007, after developing the company's proprietary HDL measurement technology and the Boston Heart Cholesterol Balance® test. Dr. Schaefer is internationally recognized as a leader in the field of lipoprotein metabolism, and the diagnosis and management of lipoprotein disorders for the prevention of CHD. Dr. Schaefer is a distinguished professor at the Tufts University School of Medicine and the Friedman School of Nutrition Science and Policy at Tufts University, senior scientist at the Human Nutrition Research Center on Aging, as well as a senior scientist in the Cardiovascular Nutrition Laboratory in Boston, MA. He received the JD Lane Award of the U.S. Public Health Service and the National Institutes of Health (NIH) (1981) and the Irvine H. Page Arteriosclerosis Research Award from the American Heart Association (1981) for defining human HDL metabolism, the metabolic defect in Tangier disease and describing two new genetic disorders apoA-I/C-III/A-IV and apoE deficiency characterized by severe lipoprotein abnormalities and premature coronary heart disease with Drs. Dr. Schaefer is an author or co-author of over 500 publications and two books on HDL metabolism and heart disease prevention. He served on the first and second adult treatment panels of the National Cholesterol Education Program of the NIH, on the Nutrition Study Section and as chairman of the Metabolism Study Section of the NIH, and the Nutrition Committee of the American Heart Association. Between 1997 and 2007 Dr. Schaefer served as the U.S. editor of the journal Atherosclerosis, and in 2009 served as the chairman of the 15th International Symposium on Atherosclerosis, held in Boston. Dr. Schaefer received his education at Harvard College, Dartmouth Medical School, and the Mount Sinai School of Medicine (MD). He did his medical residency at Mt. Sinai Hospital, New York, and an endocrinology fellowship at the National Institutes of Health, where he also served as a senior investigator and head of the clinical service of the Molecular Disease Branch of the National Heart, Lung, and Blood Institute of NIH. In 1999, Dr. Asztalos joined Dr. Schaefer's laboratory at Tufts University in Boston.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory